Yerin Kim

Dr. Yerin Kim

orcid

Research Focus & Metrics

Representative Publications

View All Publications
17 June 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HCHong-Mi Choi
Hong-Mi Choi
YKYerin Kim
Yerin Kim
JKJoonghee Kim
Joonghee Kim
JPJiesuck Park
Jiesuck Park
IHIn-Chang Hwang
In-Chang Hwang
YCYoungjin Cho
Youngjin Cho
Background: Preoperative cardiovascular risk stratification is essential in noncardiac surgery, but conventional testing is frequently overused, increasing costs without improving outcomes. Artificial intelligence (AI)–enabled electrocardiography (ECG) may enhance perioperative risk assessment by identifying surgical candidates at very low-risk for adverse events. Objective: This study aimed to evaluate whether AI-ECG–based risk stratification could help decrease low-yield preoperative cardiovascular testing and reduce associated costs, without an observed increase in postoperative adverse outcomes, in candidates for noncardiac surgery. Methods: We retrospectively analyzed 41,218 patients (46,135 ECG-surgery pairs) undergoing noncardiac surgery at Seoul National University Bundang Hospital (2020-2021). An AI-ECG algorithm generated eight probability scores for cardiac conditions, classifying cases as low- or high-risk. Based on the performance and results of preoperative cardiovascular testing (transthoracic echocardiography, coronary computed tomography angiography, single-photon emission computed tomography, or coronary angiography), cases were classified as no advanced cardiovascular imaging, negative-test, or positive-test. The primary end point was a 30-day composite of all-cause mortality and unplanned percutaneous coronary intervention. Results: AI-ECG classified 92.3% (42,599/46,135) of cases as low-risk, with a composite outcome rate of 0.2% (79/42,599) vs 2.9% (101/3536) in high-risk cases. Preoperative cardiovascular testing was performed in 11.8% (5458/46,135) of cases, with only 16.3% (892/5458) yielding positive findings. In AI-ECG low-risk cases, event rates were uniformly low (0.2%-0.4%) irrespective of whether advanced cardiovascular testing was performed, whereas in high-risk cases, rates were consistently high (2.6%-3.4%). The incidence of the composite outcome was consistently higher in AI-ECG–graded high-risk cases across all European Society of Cardiology surgical risk and Revised Cardiac Risk Index strata. Conclusions: In this retrospective cohort, a multitask AI-ECG identified surgical candidates at low-risk for postoperative complications, for whom advanced cardiovascular testing demonstrated low diagnostic yield. Integrating AI-ECG with conventional risk tools may offer an exploratory strategy to optimize resource use and minimize redundant testing. Prospective studies are needed to confirm the clinical and economic benefits of AI-ECG as a screening tool.

15 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
WYWoong Su Yoon
Woong Su Yoon
YKYerin Kim
Yerin Kim
JKJu-Seung Kwun
Ju-Seung Kwun
KJKi-Hyun Jeon
Ki-Hyun Jeon
SPSanghon Park
Sanghon Park
HCHyoung-won Cho
Hyoung-won Cho
Background/Objectives: We evaluated the feasibility of a near-infrared spectroscopy (NIRS)-guided selective strategy based on a single absolute regional tissue oxygen saturation (rSO2) threshold and described clinically overt limb ischemia. Methods: This single-center retrospective study included 110 adults receiving femoral venoarterial extracorporeal membrane oxygenation between April 2020 and December 2024. All underwent bilateral lower-extremity NIRS monitoring. In 83 patients, distal perfusion catheter (DPC) placement was triggered by rSO2 < 40% in the cannulated limb or clinically evident limb ischemia; 27 received routine prophylactic DPC placement at cannulation. Primary endpoints were DPC avoidance and clinically overt limb ischemia. Results: Extracorporeal cardiopulmonary resuscitation (ECPR) accounted for 64.5% of patients. Under the selective strategy, 45/83 patients (54.2%; exact 95% CI, 42.9–65.2%) avoided DPC placement, with no clinically overt limb ischemia (0/45; exact 95% CI, 0–7.9%). Limb ischemia occurred in 2/83 versus 2/27 patients (2.4% versus 7.4%; risk difference, −5.0 percentage points; 95% CI, −21.1 to +3.0; p = 0.252). Because threshold crossing triggered DPC placement, the reported threshold characteristics reflect the operation of the management protocol rather than independent diagnostic accuracy. Conclusions: A single-threshold NIRS-guided selective strategy was feasible in this ECPR-dominant population, allowing just over half of patients to avoid prophylactic DPC placement. No clinically overt limb ischemia was observed in this subgroup, but the upper 95% confidence limit of 7.9% precludes a definitive safety conclusion. Prospective studies are needed to assess limb ischemia risk and refine selection criteria.

10 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
YKYerin Kim
Yerin Kim
HLHaemin Lee
Haemin Lee
HCHong-Mi Choi
Hong-Mi Choi
IHIn-Chang Hwang
In-Chang Hwang
JKJoonghee Kim
Joonghee Kim
YCYoungjin Cho
Youngjin Cho
Background: Although artificial intelligence–enhanced electrocardiography (AI-ECG) has shown promise in detecting cardiac abnormalities, large-scale validation against cardiac magnetic resonance (CMR) parameters in a multiethnic general population remains limited. Methods: In 38,804 UK Biobank participants with paired ECG and CMR data, we evaluated six AI-ECG models: four targeting functional abnormalities (left and right ventricular dysfunction [QCG-LVD and QCG-RVD], global longitudinal strain [ECG-LVGLS and ECG-RVGLS]) and two targeting structural abnormalities (left ventricular hypertrophy [AI-ECG-LVH] and left atrial enlargement [AI-ECG-LAE]). Abnormalities were defined as the top 1% extreme values of each CMR-derived parameter. Results: The AI-ECG models demonstrated robust diagnostic performance. For left ventricular dysfunction, the AUCs were 0.887 (QCG-LVD) and 0.896 (ECG-LVGLS); for right ventricular dysfunction, the AUCs were 0.778 (QCG-RVD) and 0.825 (ECG-RVGLS). In a sub-cohort with available corresponding CMR data (n=21,267), AUCs were 0.824 for AI-ECG-LVH and 0.883 for AI-ECG-LAE. Subgroup analyses showed consistent performance across demographic and clinical groups, with enhanced accuracy observed in older individuals, males, and those with hypertension. Conclusion: In this large-scale, population-based study, AI-ECG demonstrated strong performance in detecting structural and functional cardiac abnormalities defined by CMR. These findings support the potential utility of AI-ECG as a scalable screening tool for cardiovascular disease in general populations.

21 December 2025 in JMIR Preprints
Verified
Preprint
Open access
HCHong-Mi Choi
Hong-Mi Choi
YKYerin Kim
Yerin Kim
JKJoonghee Kim
Joonghee Kim
JPJiesuck Park
Jiesuck Park
IHIn-Chang Hwang
In-Chang Hwang
YCYoungjin Cho
Youngjin Cho
BACKGROUND Preoperative cardiovascular risk stratification is essential in noncardiac surgery, but conventional testing is frequently overused, increasing costs without improving outcomes. Artificial intelligence (AI)–enabled electrocardiography (ECG) may enhance perioperative risk assessment by identifying surgical candidates at very low-risk for adverse events. OBJECTIVE This study aimed to evaluate whether AI-ECG–based risk stratification could help decrease low-yield preoperative cardiovascular testing and reduce associated costs, without an observed increase in postoperative adverse outcomes, in candidates for noncardiac surgery. METHODS We retrospectively analyzed 41,218 patients (46,135 ECG-surgery pairs) undergoing noncardiac surgery at Seoul National University Bundang Hospital (2020-2021). An AI-ECG algorithm generated eight probability scores for cardiac conditions, classifying cases as low- or high-risk. Based on the performance and results of preoperative cardiovascular testing (transthoracic echocardiography, coronary computed tomography angiography, single-photon emission computed tomography, or coronary angiography), cases were classified as no advanced cardiovascular imaging, negative-test, or positive-test. The primary end point was a 30-day composite of all-cause mortality and unplanned percutaneous coronary intervention. RESULTS AI-ECG classified 92.3% (42,599/46,135) of cases as low-risk, with a composite outcome rate of 0.2% (79/42,599) vs 2.9% (101/3536) in high-risk cases. Preoperative cardiovascular testing was performed in 11.8% (5458/46,135) of cases, with only 16.3% (892/5458) yielding positive findings. In AI-ECG low-risk cases, event rates were uniformly low (0.2%-0.4%) irrespective of whether advanced cardiovascular testing was performed, whereas in high-risk cases, rates were consistently high (2.6%-3.4%). The incidence of the composite outcome was consistently higher in AI-ECG–graded high-risk cases across all European Society of Cardiology surgical risk and Revised Cardiac Risk Index strata. CONCLUSIONS In this retrospective cohort, a multitask AI-ECG identified surgical candidates at low-risk for postoperative complications, for whom advanced cardiovascular testing demonstrated low diagnostic yield. Integrating AI-ECG with conventional risk tools may offer an exploratory strategy to optimize resource use and minimize redundant testing. Prospective studies are needed to confirm the clinical and economic benefits of AI-ECG as a screening tool. CLINICALTRIAL